Ruxolitinib reverses checkpoint inhibition by reducing programmed cell death ligand-1 (PD-L1) expression and increases anti-tumour effects of T cells in multiple myeloma
| Image |  |
|---|---|
| Description | scientific article published on 20 December 2020 |
| Author/s |
author: James R Berenson |
| Publication date | December 20, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |